论文部分内容阅读
近年来,人们已从多方面认识到急性淋巴细胞白血病(ALL)是一种“杂源性”疾病。利用ALL细胞的表面标志和异种抗血清可以对ALL进行免疫学分型,并且ALL的免疫分型与临床特征及预后有密切的关系。这是对ALL研究的一个重要的进展。
In recent years, people have recognized in many aspects that acute lymphoblastic leukemia (ALL) is a “heterogeneous” disease. ALL cell surface markers and heterologous antiserum can be used for immunological typing of ALL, and the immune typing of ALL is closely related to clinical features and prognosis. This is an important development for ALL research.